- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 241/10 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 241/10
Total number of patents in this class: 77
10-year publication summary
|
3
|
2
|
2
|
6
|
12
|
6
|
3
|
2
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MannKind Corporation | 527 |
10 |
| Nuvation Bio Inc. | 95 |
6 |
| Curis, Inc. | 129 |
4 |
| JNC Corporation | 1531 |
3 |
| King Abdullah University of Science and Technology | 1745 |
3 |
| F. Hoffmann-La Roche AG | 7951 |
2 |
| Janssen Pharmaceutica N.V. | 3611 |
2 |
| Semiconductor Energy Laboratory Co., Ltd. | 11114 |
2 |
| Korea Institute of Science and Technology | 2075 |
2 |
| National University Corporation Tokyo Medical and Dental University | 516 |
2 |
| Guangdong Raynovent Biotech Co., Ltd. | 44 |
2 |
| Arxada AG | 151 |
2 |
| Biopolar Youtang (Guangdong) Pharmaceutical Co., Ltd. | 2 |
2 |
| The Procter & Gamble Company | 22147 |
1 |
| Novartis AG | 11257 |
1 |
| Bristol-myers Squibb Company | 4865 |
1 |
| 3m Innovative Properties Company | 17969 |
1 |
| The Regents of the University of California | 19544 |
1 |
| Bayer Intellectual Property GmbH | 2569 |
1 |
| Fujitsu Limited | 18401 |
1 |
| Other owners | 28 |